#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10420	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2061	495.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	553	C	541	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10420	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2061	495.9	0	HET	.	.	.	C207T,G	.	207	207	C	432	432	C	620	C,T,G	341,257,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19216	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3580	531.0	0	.	n	.	0	T695C	SNP	695	695	T	1024	1024	C	548	C	541	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19216	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3580	531.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1967	1967	G	610	G,A	427,168	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19216	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3580	531.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2300	2300	C	599	C,T	577,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19216	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3580	531.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2926	2926	T	578	T,C	448,118	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19216	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3580	531.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2374	2374	A	576	A,T	563,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	6	blaTEM	861	239	99.58	blaTEM.l15.c4.ctg.1	239	1.7	0	.	p	.	0	M180T	NONSYN	538	540	ATG	62	64	ACG	2;2;2	A;C;G	2;1;2	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1334	folP	855	855	100.0	folP.l15.c4.ctg.1	1677	78.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1144	1146	AGC	138;139;140	A;G;C	133;136;134	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3786	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3474	107.8	1	SNP	p	S91F	1	.	.	271	273	TTC	583	585	TTC	103;105;105	T;T;C,G	103;104;104,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3786	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3474	107.8	1	SNP	p	G95N	0	.	.	283	285	GGC	595	597	GGC	102;102;103	G;G,A;C	102;100,1;100	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3786	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3474	107.8	1	SNP	p	D95G	1	.	.	283	285	GGC	595	597	GGC	102;102;103	G;G,A;C	102;100,1;100	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1178	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1541	75.9	1	SNP	p	G45D	0	.	.	133	135	GGC	571	573	GGC	127;127;126	G;G;C	125;126;123	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	648	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	982	65.3	0	.	n	.	0	A197.	DEL	197	197	A	558	558	A	133	A	127	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3654	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3073	117.5	1	SNP	p	D86N	0	.	.	256	258	GAC	563	565	GAC	146;145;148	G,A,C;A,C;C	143,1,1;137,1;146	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3654	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3073	117.5	1	SNP	p	R87I	0	.	.	259	261	CGT	566	568	CGT	148;146;149	C;G;T	144;141;142	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3654	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3073	117.5	1	SNP	p	R87W	0	.	.	259	261	CGT	566	568	CGT	148;146;149	C;G;T	144;141;142	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3654	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3073	117.5	1	SNP	p	S87R	1	.	.	259	261	CGT	566	568	CGT	148;146;149	C;G;T	144;141;142	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3654	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3073	117.5	1	SNP	p	S88P	0	.	.	262	264	TCC	569	571	TCC	150;150;152	T;C;C,A	142;148;147,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2748	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2781	97.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1611	1613	GGC	139;137;138	G;G;C	132;131;125	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2760	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2406	113.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1225	1227	GCC	142;144;144	G;C,A;C,A	137;139,1;139,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2760	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2406	113.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1228	1230	ATG	147;146;147	A;T,G;G,C	143;140,1;142,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2760	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2406	113.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1240	1242	ACC	149;150;150	A,G;C,T;C,G	143,1;148,1;146,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2760	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2406	113.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1240	1242	ACC	149;150;150	A,G;C,T;C,G	143,1;148,1;146,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2760	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2406	113.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1741	1743	ACC	155;156;155	A,G;C;C	148,1;153;151	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2760	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2406	113.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1795	1797	GCG	150;151;150	G;C;G	149;149;149	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2760	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2406	113.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1795	1797	GCG	150;151;150	G;C;G	149;149;149	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2760	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2406	113.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1918	1920	GGT	108;107;105	G;G;T	103;103;101	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2760	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2406	113.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1927	1929	AGC	100;100;98	A;G;C	96;95;93	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2760	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2406	113.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1945	1947	CCG	73;72;66	C,G;C;G,C	68,1;68;57,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3910	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3154	122.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1665	1667	CCG	133;134;134	C;C;G	123;129;126	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1828	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1906	94.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	557	557	C	127	C	118	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1984	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1680	117.1	0	.	p	.	0	G129S	NONSYN	385	387	GGC	675	677	AGC	140;141;140	A;G,T;C	139;137,1;139	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1984	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1680	117.1	1	SNP	p	G120K	1	.	.	358	360	AAG	648	650	AAG	140;141;142	A;A;G	133;135;132	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1984	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1680	117.1	1	SNP	p	N121D	0	.	.	361	363	AAC	651	653	AAC	141;139;139	A;A;C,A	135;133;130,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1984	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1680	117.1	1	SNP	p	A121N	1	.	.	361	363	AAC	651	653	AAC	141;139;139	A;A;C,A	135;133;130,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6916	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4935	138.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	738	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1019	70.9	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	131;131;127	A;T;G	130;129;126	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
